These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. Hudson BD; Christiansen E; Tikhonova IG; Grundmann M; Kostenis E; Adams DR; Ulven T; Milligan G FASEB J; 2012 Dec; 26(12):4951-65. PubMed ID: 22919070 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, activity, and docking study of phenylthiazole acids as potential agonists of PPARγ. Ma L; Wang T; Shi M; Ye H Drug Des Devel Ther; 2016; 10():1807-15. PubMed ID: 27313447 [TBL] [Abstract][Full Text] [Related]
24. Exploration of the nitrogen heterocyclic periphery around the core of the advanced FFA1 agonist fasiglifam (TAK-875). Lukin A; Bakholdina A; Zhurilo N; Onopchenko O; Zhuravel E; Zozulya S; Gureev M; Safrygin A; Krasavin M Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000275. PubMed ID: 33270252 [TBL] [Abstract][Full Text] [Related]
25. Chemogenetics defines receptor-mediated functions of short chain free fatty acids. Bolognini D; Barki N; Butcher AJ; Hudson BD; Sergeev E; Molloy C; Moss CE; Bradley SJ; Le Gouill C; Bouvier M; Tobin AB; Milligan G Nat Chem Biol; 2019 May; 15(5):489-498. PubMed ID: 30992568 [TBL] [Abstract][Full Text] [Related]
26. The Specificity and Broad Multitarget Properties of Ligands for the Free Fatty Acid Receptors FFA3/GPR41 and FFA2/GPR43 and the Related Hydroxycarboxylic Acid Receptor HCA2/GPR109A. Bisenieks E; Vigante B; Petrovska R; Turovska B; Muhamadejev R; Soloduns V; Velena A; Pajuste K; Saso L; Klovins J; Duburs G; Mandrika I Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681211 [TBL] [Abstract][Full Text] [Related]
27. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats. Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941 [TBL] [Abstract][Full Text] [Related]
28. A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias. Bolognini D; Moss CE; Nilsson K; Petersson AU; Donnelly I; Sergeev E; König GM; Kostenis E; Kurowska-Stolarska M; Miller A; Dekker N; Tobin AB; Milligan G J Biol Chem; 2016 Sep; 291(36):18915-31. PubMed ID: 27385588 [TBL] [Abstract][Full Text] [Related]
29. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. Le Poul E; Loison C; Struyf S; Springael JY; Lannoy V; Decobecq ME; Brezillon S; Dupriez V; Vassart G; Van Damme J; Parmentier M; Detheux M J Biol Chem; 2003 Jul; 278(28):25481-9. PubMed ID: 12711604 [TBL] [Abstract][Full Text] [Related]
39. Discovery of a novel potent GPR40 full agonist. Meegalla SK; Huang H; Martin T; Xu J; Zhao S; Liu J; Hall M; Gunnet J; Wang Y; Rady B; Silva J; Otieno M; Arnoult E; Paul Lee S; Pocai A; Player MR Bioorg Med Chem Lett; 2018 Feb; 28(4):720-726. PubMed ID: 29366647 [TBL] [Abstract][Full Text] [Related]